Trials / Withdrawn
WithdrawnNCT06967064
The Application of Lidocaine Cream on Oral Secretions of LMA Removal During the Recovery Period in Ophthalmic Surgical Patients Under General Anesthesia
The Application of Lidocaine Cream on Oral Secretions of LMA Removal During the Recovery Period in Ophthalmic Surgical Patients Under General Anesthesia: a Randomized Controlled Trial
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The application of lidocaine cream on oral secretions of LMA removal during the recovery period in ophthalmic surgical patients under general anesthesia: a randomized controlled trial
Detailed description
During the recovery from general anesthesia, patients commonly experience heightened oral secretions, which can elevate intraocular pressure (IOP) due to coughing and potentially lead to the infiltration of secretions into the surgical site via the nasolacrimal duct, increasing the risk of endophthalmitis. This study is aimed to investigate whether applying lidocaine cream to the laryngeal mask airway (LMA) reduces oral secretions during emergence from general anesthesia in ophthalmic surgery patients.
Conditions
- Airway Complication of Anaesthesia
- Laryngeal Mask Airway Removal
- Anesthesia Emergence
- Secretion; Excess, Salivation
- Ophthalmic Surgery
- General Anesthesia
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lidocaine cream | Group U receives 1 mL of lidocaine cream extracted using a syringe and evenly applied across the entire posterior surface of the LMA cuff by carefully spreading the cream to ensure uniform coverage, while Group N receives 1 mL of lidocaine cream also extracted using a syringe but applied without ensuring even distribution, resulting in a patchy or non-uniform application. |
| OTHER | Placebo | No lidocaine cream will be applied to the LMA |
Timeline
- Start date
- 2025-05-15
- Primary completion
- 2025-05-22
- Completion
- 2025-05-22
- First posted
- 2025-05-13
- Last updated
- 2025-05-29
Source: ClinicalTrials.gov record NCT06967064. Inclusion in this directory is not an endorsement.